OBJECTIVE: To estimate the direct (medical and prescription drug) and indirect (work loss) costs of children treated for attention-deficit/hyperactivity disorder (ADHD) and their family members. METHOD: The data source was an administrative database from a national, Fortune 100 manufacturer that included all medical, pharmaceutical, and disability claims for beneficiaries (n > 100,000). The analysis involved four samples. The ADHD patient sample included individuals age 18 or younger with at least one ADHD claim during the study period (1996-1998). Resource utilization of ADHD patients was contrasted with a matched control sample of patients who did not have claims for ADHD. The ADHD and non-ADHD family samples included non-ADHD family members of ADHD patients and their matched controls. RESULTS: The annual average expenditure (direct cost) per ADHD patient was $1,574, compared to $541 among matched controls. The annual average payment (direct plus indirect cost) per family member was $2,728 for non-ADHD family members of ADHD patients versus $1,440 for family members of matched controls. Both patient and family cost differences were significant at the 95% confidence level. CONCLUSIONS: ADHD imposes a significant financial burden regarding the cost of medical care and work loss for patients and family members.
OBJECTIVE: To estimate the direct (medical and prescription drug) and indirect (work loss) costs of children treated for attention-deficit/hyperactivity disorder (ADHD) and their family members. METHOD: The data source was an administrative database from a national, Fortune 100 manufacturer that included all medical, pharmaceutical, and disability claims for beneficiaries (n > 100,000). The analysis involved four samples. The ADHDpatient sample included individuals age 18 or younger with at least one ADHD claim during the study period (1996-1998). Resource utilization of ADHDpatients was contrasted with a matched control sample of patients who did not have claims for ADHD. The ADHD and non-ADHD family samples included non-ADHD family members of ADHDpatients and their matched controls. RESULTS: The annual average expenditure (direct cost) per ADHDpatient was $1,574, compared to $541 among matched controls. The annual average payment (direct plus indirect cost) per family member was $2,728 for non-ADHD family members of ADHDpatients versus $1,440 for family members of matched controls. Both patient and family cost differences were significant at the 95% confidence level. CONCLUSIONS:ADHD imposes a significant financial burden regarding the cost of medical care and work loss for patients and family members.
Authors: Katharine E Zuckerman; Kimber M Mattox; Brianna K Sinche; Gregory S Blaschke; Christina Bethell Journal: Clin Pediatr (Phila) Date: 2013-09-10 Impact factor: 1.168
Authors: Anne W Riley; David Coghill; Christopher B Forrest; Maria J Lorenzo; Stephen J Ralston; Georg Spiel Journal: Eur Child Adolesc Psychiatry Date: 2006-12 Impact factor: 4.785
Authors: Sarah D Ronis; Constance D Baldwin; Scott McIntosh; Kenneth McConnochie; Peter G Szilagyi; James Dolan Journal: Clin Pediatr (Phila) Date: 2015-01-07 Impact factor: 1.168
Authors: Hanna Kovshoff; May Vrijens; Margaret Thompson; Lucy Yardley; Paul Hodgkins; Edmund J S Sonuga-Barke; Marina Danckaerts Journal: Eur Child Adolesc Psychiatry Date: 2013-03-02 Impact factor: 4.785
Authors: Katherine E Lawrence; Jennifer G Levitt; Sandra K Loo; Ronald Ly; Victor Yee; Joseph O'Neill; Jeffry Alger; Katherine L Narr Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-03-07 Impact factor: 8.829
Authors: Oscar G Bukstein; L Eugene Arnold; Jeanne M Landgraf; Paul Hodgkins Journal: Child Adolesc Psychiatry Ment Health Date: 2009-12-10 Impact factor: 3.033